Sort   by:  
 Page size 
TranscriptomicsRespective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
Phenotypic and genomic characterization of Early Stage Breast Carcinoma using Training set (n=109) Validation set (n=105) of SNP6 arrays Affymetrix SNP6.0 arrays were performed according to the manufacturer's directions on DNA extracted from cryopreserved breast tumoral samples.
ORGANISM(S): Homo sapiens 
2014-02-18 | E-GEOD-48064 | biostudies-arrayexpress
MetabolomicsOxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
Resistance to endocrine treatments and CDK4/6 inhibitors is considered a near-inevitability in most patients with estrogen receptor positive breast cancers (ER + BC). By genomic and metabolomics analyses of patients' tumours, metastasis-derived patient-derived xenografts (PDX) and isogenic cell line...
2023-06-27 | MTBLS3342 | MetaboLights
UnknownRespective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma.
Not available
S-EPMC3329444 | biostudies-literature
UnknownAssociation of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study.
Not available
S-EPMC6927582 | biostudies-literature
UnknownChemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer.
Not available
S-EPMC10654794 | biostudies-literature
UnknownVEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study.
Not available
S-EPMC7700430 | biostudies-literature
UnknownLong-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
Not available
S-EPMC9954606 | biostudies-literature
UnknownComparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
Not available
S-EPMC9478776 | biostudies-literature
UnknownReal-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
Not available
S-EPMC7841864 | biostudies-literature
UnknownImpact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.
Not available
S-EPMC6964671 | biostudies-literature
Sort   by:  
 Page size